aramisbio.com | Aramis Biosciences - Disease-Modifying Therapy for Ocular Surface

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔
User-agent: * Disallow: /wp-admin/ Allow: /wp-admin/admin-ajax.php Sitemap:

Meta Tags

Title	Aramis Biosciences - Disease-Modifying Therapy for Ocular Surface
Description	Disease‑Modifying Therapy for Ocular Surface Aramis Biosciences is a clinical-stage immuno-ophthalmology biopharmaceutical company committed to the development of disease-modifying therapy for ocular surface
Keywords	N/A

Server Information

WebSite	aramisbio.com
Host IP	162.159.135.42
Location	United States

Related Websites

                        Site
                        Rank
                    

More to Explore

aramisbio.com Valuation

US$2,676,095

Last updated: 2023-05-16 09:09:37

aramisbio.com has Semrush global rank of 3,955,131. aramisbio.com has an estimated worth of US$ 2,676,095, based on its estimated Ads revenue. aramisbio.com receives approximately 308,781 unique visitors each day. Its web server is located in United States, with IP address 162.159.135.42. According to SiteAdvisor, aramisbio.com is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$2,676,095
Daily Ads Revenue	US$2,471
Monthly Ads Revenue	US$74,108
Yearly Ads Revenue	US$889,287
Daily Unique Visitors	20,586
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
aramisbio.com.	A	898	IP: 162.159.135.42
aramisbio.com.	NS	21600	NS Record: ns3.p30.dynect.net.
aramisbio.com.	NS	21600	NS Record: ns2.p30.dynect.net.
aramisbio.com.	NS	21600	NS Record: ns1.p30.dynect.net.
aramisbio.com.	NS	21600	NS Record: ns4.p30.dynect.net.
aramisbio.com.	MX	3600	MX Record: 10 us-smtp-inbound-2.mimecast.com.
aramisbio.com.	MX	3600	MX Record: 10 us-smtp-inbound-1.mimecast.com.
aramisbio.com.	TXT	300	TXT Record: v=spf1 include:_netblocks.mimecast.com -all
aramisbio.com.	TXT	300	TXT Record: ca3-d17af3a648a744b1a1d9d775c6fbd16c

HtmlToTextCheckTime:2023-05-16 09:09:37

Aramis Biosciences Toggle menu Close Home About Pipeline News Contact Disease‑Modifying Therapy for Ocular Surface Disease While 17.8 million people have been diagnosed with Dry Eye Disease in the United States… Fewer than 1 million (1 in 20) are currently treated with an FDA-approved product; presumably due to questionable efficacy and tolerability limitations. Less than 5% (1 in 20) of Dry Eye Disease patients are currently treated with a FDA-approved product Aramis Biosciences is a clinical-stage immuno‑ophthalmology biopharmaceutical company committed to the development of disease‑modifying therapy for ocular surface disease Learn more about Aramis Biosciences News Aramis Biosciences Completes Enrollment of its Phase II Clinical Trial Evaluating A197 for the Treatment of Dry Eye Disease November 3, 2022 Read more Aramis Biosciences Announces First Patient Dosed in Phase II Clinical Trial Evaluating A197 for the Treatment of Dry Eye Disease February 28, 2022 Read more See all

HTTP Headers

HTTP/1.1 301 Moved Permanently
Date: Fri, 21 Jan 2022 11:22:58 GMT
Content-Type: text/html
Content-Length: 162
Connection: keep-alive
Location: https://aramisbio.com/
CF-Ray: 6d102aef0d05f146-ARN
CF-Cache-Status: DYNAMIC
ki-edge: v=16.8
X-Content-Type-Options: nosniff
X-Edge-Location-Klb: 1
Server: cloudflare
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400

HTTP/2 200 
date: Fri, 21 Jan 2022 11:22:58 GMT
content-type: text/html; charset=UTF-8
cf-ray: 6d102af13bf91691-ARN
link: ; rel="https://api.w.org/", ; rel="alternate"; type="application/json", ; rel=shortlink
vary: Accept-Encoding
cf-cache-status: DYNAMIC
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
ki-edge: v=16.8
x-content-type-options: nosniff
x-edge-location-klb: 1
x-kinsta-cache: MISS
server: cloudflare
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400

aramisbio.com Whois Information

Domain Name: ARAMISBIO.COM
Registry Domain ID: 2185110773_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.godaddy.com
Registrar URL: http://www.godaddy.com
Updated Date: 2021-11-10T15:57:12Z
Creation Date: 2017-11-09T18:12:13Z
Registry Expiry Date: 2022-11-09T18:12:13Z
Registrar: GoDaddy.com, LLC
Registrar IANA ID: 146
Registrar Abuse Contact Email: abuse@godaddy.com
Registrar Abuse Contact Phone: 480-624-2505
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS1.P30.DYNECT.NET
Name Server: NS2.P30.DYNECT.NET
Name Server: NS3.P30.DYNECT.NET
Name Server: NS4.P30.DYNECT.NET
DNSSEC: unsigned
>>> Last update of whois database: 2022-01-21T07:48:36Z <<<

aramisbio.com valuation and analysis